Form D · Pharmaceuticals
KannaLife Sciences, Inc.
West Hills, NY · CIK 0001538856
Offering snapshot reported Apr 30, 2013 · SEC filing
- Reported sold
- $1.5M Offering amount: $1.5M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 4, 2013 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 30, 2013 | Initial | $1,500,000 | No comparison | 2 | SEC filing |
| Feb 3, 2012 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-195740
Source: Form D, filed Apr 30, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Mark Corrao | Executive |
| W. Dennis Drehkoff | Director, Executive |
| Thomas Kikis | Director, Executive |
| Thoma Kikis | Director, Executive |
| Michael Mona, Jr. | Director |
| Ramesh Pandey | Director, Executive |
| Dean Petkanas | Director, Executive |
| Stuart Titus | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
363 West Hills Road
West Hills, NY, 11743
West Hills, NY, 11743